After getting the CE marking, Spineart is proud to announce that we received the FDA 510(k) clearance for the new Minimal Invasive Thoracolumbar Posterior Fixation System, PERLA® TL MIS on January 15th, 2021.
PERLA® TL MIS is a comprehensive system including polyaxial screws with Extended Tabs which enable a connection to different rod diameters. It contributes to the treatment of spinal pathologies through Percutaneous and Minimal Invasive Surgeries and perfectly complements the new PERLA® TL solutions designed for the treatment of degenerative pathologies.
Further extensions of the PERLA® TL solution are expected to come.
About SpineArt
Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients.Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment. Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.http://www.spineart.com